Product Introduction
The coating is chemically bonded to the surface of devices, grafting modified heparin onto the surface of the medical devices, effectively inhibiting formation of thrombus. During long term use, the coating can still maintain its integrity and function, and will not degrade with use.
Product Advantages
- Hygea® heparin coating shows a significant anticoagulant effect, through effectively reducing protein and platelet adhesion, thus reducing thrombus formation.
- It has good biocompatibility.
- During long term use, the coating retains its integrity and function.
- Coating thickness is at the nanometer level.
Application product
jMedtech has been incorporated its antithrombogenic coatings into 11 different products, showcasing a broad foundation of uses and extensive experience. The coated products have demonstrated a significant anti-coagulative effect.
- Stent grafts
- Metal implants
- Introducer sheaths
- Central Venous Catheter (CVC)
- Heart valves
- Vascular grafts
- Neurological guidewires and catheters
- Haemodialysis catheters
- Embolic protection devices
- Vena cava filters
- Peripherally Inserted Central Catheter (PICC)
- Others
Performance Tests
We have done a series of experiments with heparin coating, here are the results
SEM
Uncoated PU
PU coated with cured heparin coating
Comparison of Static Thrombus Test
Grafted Stent
No Coating
With Coating
ECMO-PMP
No Coating
With Coating
PICC
No Coating
With Coating
Extracorporeal Circulation Catheter
No Coating
With Coating
Technical Resources
Download more information on how our Hygea® Heparin Antithrombogenic Coating and expertise can tackle unmet needs.
Heparin Antithrombogenic Coating & Phosphorylcholine Hemocompatible Coating
